Author Search Results

E. Premkumar Reddy

E. Premkumar Reddy is a molecular biologist specialising in molecular oncology. He is the Director of Experimental Cancer Therapeutics program and Professor in the Departments of Oncological Sciences and Structural and Chemical Biology at the Mount Sinai School of Medicine. Provided by Wikipedia

1

Neoplastic Transformation Induced by the gep Oncogenes Involves the Scaffold Protein JNK-Interacting Leucine Zipper Protein

by Kimia Kashef, Rangasudhagar Radhakrishnan, Clement M. Lee, E. Premkumar Reddy, Danny N. Dhanasekaran
Published 2011-04-01

Get full text

Article
2

ON01210.Na (Ex-RAD®) mitigates radiation damage through activation of the AKT pathway.

by Anthony D Kang, Stephen C Cosenza, Marie Bonagura, Manoj Manair, M V Ramana Reddy, E Premkumar Reddy
Published 2013-01-01

Get full text

Article
3

An In Vivo Functional Screen Uncovers miR-150-Mediated Regulation of Hematopoietic Injury Response

by Brian D. Adams, Shangqin Guo, Haitao Bai, Yanwen Guo, Cynthia M. Megyola, Jijun Cheng, Kartoosh Heydari, Changchun Xiao, E. Premkumar Reddy, Jun Lu
Published 2012-10-01

Get full text

Article
4

Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade

by Chi Yan, Nabil Saleh, Jinming Yang, Caroline A. Nebhan, Anna E. Vilgelm, E. Premkumar Reddy, Joseph T. Roland, Douglas B. Johnson, Sheau-Chiann Chen, Rebecca L. Shattuck-Brandt, Gregory D. Ayers, Ann Richmond
Published 2021-06-01

Get full text

Article
5

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease

by Katsutoshi Sato, Amol A. Padgaonkar, Stacey J. Baker, Stephen C. Cosenza, Olga Rechkoblit, D. R. C. Venkata Subbaiah, Josep Domingo-Domenech, Alison Bartkowski, Elisa R. Port, Aneel K. Aggarwal, M. V. Ramana Reddy, Hanna Y. Irie, E. Premkumar Reddy
Published 2021-08-01

Get full text

Article